BE Board:Industrial seminar series

Upcoming Speakers
September 23, 2005 - * Special Bioethics Seminar * Stempsey (College of Holy Cross)

October 28, 2005 - * Special Bioethics Seminar * Thomas Shannon (Worcester Polytechnic Institute)

December 2, 2005 Mark Trusheim (Massachusetts Biotechnology Council) - 56-114 1:30 - 2:30 pm

Past Speakers
Dr. Paul Mason (Genzyme) "Drug discovery at Genzyme"
 * July 22, 2005

Dr. Gyan Bhanot (IBM Life Sciences) "Systems biology and supercomputing at IBM Life Sciences"
 * June 10, 2005

Dr. Damon Demady (Biogen Idec) "Challenges of drug development: By the book vs. reality"
 * May 20, 2005

Dr. Jinping Gan (Bristol-Myers Squibb) "Reactive metabolites in drug discovery"
 * April 22, 2005

John Essigmann (MIT BE & CEHS) "De-mystification of the grant application process for new academic investigators"
 * April 15, 2005

Nancy Briefs (President & CEO of Percardia) "A long winding road: From patent to PMA"
 * April 8, 2005

Dr. Can Ozbal (BioTrove Inc.) "Mass spectroscopy-based label-free ultra-high throughput screening for drug discovery"
 * March 25, 2005

Dr. Jonathan Gertler (Adams Harkness) "Market dynamics & financial strategies in life science technologies"
 * March 11, 2005

Dr. Cindy Xia (Millenium) "From ABC to SLC: Evaluation of drug transporters in drug discovery and development"
 * February 25, 2005

Dr. Keith Hoffmaster (Pfizer Inc.) "ADME in drug discovery & cholestasis as a mechanism of hepatotoxicity"
 * February 11, 2005

'''Drs. Birgit Schoeberl & Brian Harms (Merrimack Pharmaceuticals Inc.)''' "Starting a career in industry as an MIT alum"
 * December 13, 2004

Dr. Vicki Sato (President of Vertex Pharmaceuticals Inc.) "Careers in academia & in industry"
 * November 22, 2004

Prof. Michael Lysaght (Brown University) "After the PhD: Career decisions in biomedical engineering"
 * October 5, 2004 (see picture :))